Qu et al. [33] reported that therapies targeting the PI3K/Akt signaling pathway in hepatocellular carcinoma showed anticancer effects by promoting autophagy and the apoptosis of tumor cells. Here, AKT1 is linked to hepatocellular carcinoma.